Forum

Your browser does not seem to support JavaScript. As a result, your viewing experience will be diminished, and you have been placed in read-only mode.

Please download a browser that supports JavaScript, or enable it if it's disabled (i.e. NoScript).

PAAB Notice

The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB), including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.

505 - Dear PAAB - would a branded APS comprised of only a provincial listing (with clinical criteria/notes), require high-level balance or low-level balance? Note this assumes that all listing criteria is on-label.

Disclosure requirements: PI & Safety Information, Federal schedule, study parameters, reference lists

1 Posts 1 Posters 252 Views

J Online
J Online
Jennifer Carroll

wrote on last edited by

#1

Lowest provided the criteria does not include a claim which triggers highest level (e.g. efficacy/safety claim) or middle (e.g. pharmacokinetic claim).
1 Reply Last reply

0